Rok Grahek

Title: Rok Grahek - Innovator in Pharmaceutical Formulations

Introduction

Rok Grahek is a notable inventor based in Ljubljana, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative formulations. His work focuses on improving the solubility and efficacy of pharmaceutical compounds.

Latest Patents

Rok Grahek holds a patent for an afatinib-containing formulation. The patent describes a process for preparing granules or particles comprising afatinib dimaleate. This process involves providing afatinib dimaleate along with at least one pharmaceutically acceptable excipient. The preparation of granules or particles utilizes at least one solvent selected from organic solvents and water. All excipients used in this process have neutral or acidic properties, and afatinib dimaleate has a solubility of at least 5 mg/ml in the chosen solvent. The invention also includes granules or particles prepared according to this process, as well as a pharmaceutical composition for treating certain diseases.

Career Highlights

Throughout his career, Rok Grahek has worked with various companies, including Sandoz AG. His experience in the pharmaceutical industry has allowed him to develop innovative solutions that address critical health challenges. His patent reflects his commitment to advancing medical treatments through scientific research and development.

Collaborations

Rok has collaborated with notable colleagues such as Jan Pelipenko and Katja Kristan. These partnerships have contributed to the successful development of his innovative formulations.

Conclusion

Rok Grahek is a distinguished inventor whose work in pharmaceutical formulations has the potential to impact the treatment of various diseases. His innovative approach and dedication to research exemplify the spirit of invention in the pharmaceutical industry.